Patrick J. Hanley

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma.